OTCMKTS:SGBI - Sangui Biotech International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0229 -0.01 (-21.03 %) (As of 01/18/2019 04:00 PM ET)Previous Close$0.0290Today's Range$0.0229 - $0.022952-Week Range$0.0150 - $0.0790Volume1,000 shsAverage Volume15,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through Internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is based in Witten, Germany. Receive SGBI News and Ratings via Email Sign-up to receive the latest news and ratings for SGBI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SGBI Previous Symbol CUSIPN/A Webwww.sanguibiotech.com Phone+49-2302-915200Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1 Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Sangui Biotech International (OTCMKTS:SGBI) Frequently Asked Questions What is Sangui Biotech International's stock symbol? Sangui Biotech International trades on the OTCMKTS under the ticker symbol "SGBI." Has Sangui Biotech International been receiving favorable news coverage? Headlines about SGBI stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sangui Biotech International earned a news impact score of -1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. Who are some of Sangui Biotech International's key competitors? Some companies that are related to Sangui Biotech International include 22nd Century Group (XXII), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE) and Ampliphi Biosciences (APHB). Who are Sangui Biotech International's key executives? Sangui Biotech International's management team includes the folowing people: Mr. Thomas Striepe, CEO, Pres, CFO & Exec. Director (Age 54) How do I buy shares of Sangui Biotech International? Shares of SGBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Sangui Biotech International's stock price today? One share of SGBI stock can currently be purchased for approximately $0.0229. What is Sangui Biotech International's official website? The official website for Sangui Biotech International is http://www.sanguibiotech.com/. How can I contact Sangui Biotech International? Sangui Biotech International's mailing address is c/o SanguiBioTech GmbH Alfred-Herrhausen-Str. 44, WITTEN, UT 58455, Germany. The company can be reached via phone at +49-2302-915200. MarketBeat Community Rating for Sangui Biotech International (OTCMKTS SGBI)Community Ranking: 3.5 out of 5 ( )Outperform Votes: 25 (Vote Outperform)Underperform Votes: 11 (Vote Underperform)Total Votes: 36MarketBeat's community ratings are surveys of what our community members think about Sangui Biotech International and other stocks. Vote "Outperform" if you believe SGBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGBI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/18/2019 by MarketBeat.com StaffFeatured Article: What is a balanced fund?